Phytoecdysteroids and anabolic-androgenic steroids-structure and effects on humans M Báthori, N Tóth, A Hunyadi, Á Márki, E Zador Current medicinal chemistry 15 (1), 75-91, 2008 | 248 | 2008 |
μ-Opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S] GTPγS binding assays A Marki, K Monory, F Ötvös, G Toth, R Krassnig, H Schmidhammer, ... European journal of pharmacology 383 (2), 209-214, 1999 | 55 | 1999 |
Synthesis and receptor-binding examinations of the normal and 13-epi-D-homoestrones and their 3-methyl ethers J Wölfling, E Mernyák, É Frank, G Falkay, Á Márki, R Minorics, ... Steroids 68 (3), 277-288, 2003 | 54 | 2003 |
Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: preparation, characterization, and in vivo evaluation A Alshweiat, II Csóka, F Tömösi, T Janáky, A Kovács, R Gáspár, ... International journal of pharmaceutics 579, 119166, 2020 | 53 | 2020 |
Metabolic effects of mulberry leaves: exploring potential benefits in type 2 diabetes and hyperuricemia A Hunyadi, E Liktor-Busa, Á Márki, A Martins, N Jedlinszki, TJ Hsieh, ... Evidence-Based Complementary and Alternative Medicine 2013, 2013 | 51 | 2013 |
In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration L Kürti, R Gáspár, Á Márki, E Kápolna, A Bocsik, S Veszelka, C Bartos, ... European Journal of Pharmaceutical Sciences 50 (1), 86-92, 2013 | 50 | 2013 |
Pregnancy-induced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone R Gáspár, E Ducza, A Mihályi, A Márki, Z Kolarovszki-Sipiczki, E Páldy, ... Reproduction 130 (1), 113-122, 2005 | 44 | 2005 |
Study of sodium hyaluronate-based intranasal formulations containing micro-or nanosized meloxicam particles C Bartos, R Ambrus, P Sipos, M Budai-Szűcs, E Csányi, R Gáspár, ... International journal of pharmaceutics 491 (1-2), 198-207, 2015 | 41 | 2015 |
Antiproliferative effect of normal and 13-epi-D-homoestrone and their 3-methyl ethers on human reproductive cancer cell lines R Minorics, N Bózsity, J Woelfling, E Mernyak, G Schneider, A Marki, ... The Journal of Steroid Biochemistry and Molecular Biology 132 (1-2), 168-175, 2012 | 37 | 2012 |
Synthesis and receptor-binding examination of 16-hydroxymethyl-3, 17-estradiol stereoisomers P Tapolcsányi, J Wölfling, G Falkay, Á Márki, R Minorics, G Schneider Steroids 67 (7), 671-678, 2002 | 37 | 2002 |
Development of meloxicam-human serum albumin nanoparticles for nose-to-brain delivery via application of a quality by design approach G Katona, GT Balogh, G Dargó, R Gáspár, Á Márki, E Ducza, ... Pharmaceutics 12 (2), 97, 2020 | 36 | 2020 |
New nepenthone and thevinone derivatives J Marton, C Simon, S Hosztafi, Z Szabó, Á Márki, A Borsodi, S Makleit Bioorganic & Medicinal Chemistry 5 (2), 369-382, 1997 | 33 | 1997 |
Effect of solubility enhancement on nasal absorption of meloxicam T Horváth, R Ambrus, G Völgyi, M Budai-Szűcs, Á Márki, P Sipos, ... European Journal of Pharmaceutical Sciences 95, 96-102, 2016 | 27 | 2016 |
Investigation of absorption routes of meloxicam and its salt form from intranasal delivery systems C Bartos, R Ambrus, A Kovács, R Gáspár, A Sztojkov-Ivanov, Á Márki, ... Molecules 23 (4), 784, 2018 | 22 | 2018 |
An Intraperitoneally Administered Pentapeptide Protects Against Aβ 1–42 Induced Neuronal Excitation In Vivo G Juhász, Á Márki, G Vass, L Fülöp, D Budai, B Penke, G Falkay, ... Journal of Alzheimer's Disease 16 (1), 189-196, 2009 | 22 | 2009 |
Characterization of late-pregnant rat uterine contraction via the contractility ratio in vitro Significance of α1-adrenoceptors R Gáspár, I Földesi, J Havass, A Marki, G Falkay Life sciences 68 (10), 1119-1129, 2001 | 22 | 2001 |
Investigation of estrogen receptor α and β mRNA expression in the pregnant rat uterus R Minorics, E Ducza, Á Márki, E PÁldy, G Falkay Molecular Reproduction and Development: Incorporating Gamete Research 68 (4 …, 2004 | 20 | 2004 |
Structurally novel group of ligands selective for kappa opioid receptors A Borsodi, S Benyhe, U Holzgrabe, Á Márki, C Nachtsheim Regulatory Peptides 54 (1), 27-28, 1994 | 20 | 1994 |
Evidence of non-synaptic regulation of postpartum uterine contractility in the rat R Gáspár, A Márki, I Zupkó, G Falkay Life sciences 62 (12), 1119-1124, 1998 | 19 | 1998 |
β2-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: In vitro and in silico studies AAE Ahmed, A Marki, R Gaspar, A Vasas, MME Mudawi, J Verli, B Jójárt, ... European journal of pharmacology 667 (1-3), 348-354, 2011 | 17 | 2011 |